Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New PET ligand allows in vivo pharmacological evaluation of agents targeting mutant HTT expression

Feb. 9, 2022

Researchers divulge SSTR4 agonists for treatment of pain

Feb. 8, 2022

Mindset to initiate proof-of-concept preclinical studies on Family 3 compounds for cognitive benefit

Feb. 7, 2022

Parkinson's UK and Domainex collaborate to target neuroinflammation to slow Parkinson's disease

Feb. 7, 2022

Selenium mediates neurogenesis after hippocampal injury

Feb. 7, 2022

Tactogen patents 5-HT1B receptor agonists and MAO-A inhibitors

Feb. 7, 2022

University of Tokyo discloses BDNF/NT-3 growth factor receptor activators

Feb. 4, 2022

New T-type calcium channel blockers identified at Sumitomo Dainippon Pharma

Feb. 4, 2022

Researchers present preclinical model of ALS

Feb. 4, 2022

Meta-analysis reveals candidate variants associated with brain traits

Feb. 4, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...